Paeds Vivas · infectious-diseases
Pertussis — branching viva
Branching structured-oral viva on pertussis: the pathophysiology of ciliary paralysis and toxin injury, the classic three-stage course and the atypical infant presentation, PCR versus serology, macrolide treatment, isolation and notification, chemoprophylaxis, and the maternal-Tdap and cocoon prevention strategy with the waning-immunity resurgence problem.
On this page
Study tools
Target exams
Opening question
Examiner: Take me through this infant. What is the most likely diagnosis, and what is your frame for managing it? [8]
Candidate: The most likely diagnosis is pertussis. The combination of apnoea and cyanosis in a ten-week-old, a three-week household cough contact in the mother, and the infant being between doses of the DTaP schedule is classic for infant pertussis — and the whoop is often absent at this age, so apnoea may be the only sign. My frame is two-layered: support and protect this infant now, and run the public-health response to stop transmission to other vulnerable contacts. I would admit for monitoring, confirm with PCR, start a macrolide, isolate, notify and trace contacts. [8] [1]
Examiner: Why is the infant at particular risk? [8]
Candidate: Infants under six months carry the highest morbidity and mortality in pertussis. They are often too young to have completed the primary series, so they depend on maternal antibody and the immunity of the people around them. Their small airways and limited respiratory reserve turn the same toxin-mediated injury that causes a prolonged cough in an older child into apnoea, cyanosis, pneumonia and, through hypoxia, encephalopathy. The biology is the same; the host turns it lethal. [8]
References6ShowHide
- [1]WHO Pertussis vaccines: WHO position paper, August 2015--Recommendations. Vaccine, 2016.PMID 26562318
- [2]Ward JI; Cherry JD; Chang SJ; Partridge S; et al Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med, 2005.PMID 16221778
- [4]Altunaiji S; Kukuruzovic R; Curtis N; Massie J Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev, 2007.PMID 17636756
- [6]Warfel JM; Zimmerman LI; Merkel TJ Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis. Clin Vaccine Immunol, 2016.PMID 26561389
- [8]Skoff TH; Deng L; Bozio CH; Hariri S US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine. JAMA Pediatr, 2023.PMID 36745442
- [10]Alvarez J; Godoy P; Plans-Rubio P; Camps N; et al Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012-2013. Emerg Infect Dis, 2020.PMID 33079034